Coverage
-
October 17, 2016
Nursing home pharmacy Omnicare Inc. will pay $28 million to resolve False Claims Act allegations that it took kickbacks from Abbott Laboratories in exchange for prescribing epilepsy drug Depakote to vulnerable patients, the U.S. Department of Justice announced Monday.
4 other articles on this case.
View all »